BOSTON SCIENTIFIC CORP Quarterly Goodwill in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Boston Scientific Corp quarterly Goodwill history and growth rate from Q1 2010 to Q2 2024.
  • Boston Scientific Corp Goodwill for the quarter ending June 30, 2024 was $14.4B, a 5.4% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $14.4B +$738M +5.4% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $14.4B +$1.09B +8.23% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $14.4B +$1.47B +11.4% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $13.6B +$756M +5.88% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $13.7B +$776M +6.02% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $13.3B +$320M +2.47% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $12.9B +$932M +7.77% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $12.9B +$1.03B +8.73% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $12.9B +$2.01B +18.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $12.9B +$2.08B +19.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $12B +$2.04B +20.5% Dec 31, 2021 10-K 2024-02-20
Q3 2021 $11.8B +$1.68B +16.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $10.9B +$773M +7.65% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $10.9B +$770M +7.63% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $9.95B -$225M -2.21% Dec 31, 2020 10-K 2023-02-23
Q3 2020 $10.1B +$122M +1.22% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $10.1B +$1.65B +19.5% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $10.1B +$1.92B +23.5% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $10.2B +$2.27B +28.6% Dec 31, 2019 10-K 2022-02-23
Q3 2019 $10B +$2.43B +32% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $8.45B +$1.21B +16.7% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 $8.18B +$1.2B +17.1% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $7.91B +$913M +13% Dec 31, 2018 10-K 2021-02-23
Q3 2018 $7.59B +$706M +10.3% Sep 30, 2018 10-Q 2018-10-29
Q2 2018 $7.24B +$371M +5.4% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $6.98B +$304M +4.55% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 $7B +$320M +4.79% Dec 31, 2017 10-K 2020-02-25
Q3 2017 $6.88B +$384M +5.91% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $6.87B +$396M +6.12% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $6.68B +$203M +3.13% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $6.68B +$205M +3.17% Dec 31, 2016 10-K 2019-02-19
Q3 2016 $6.5B +$30M +0.46% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $6.48B +$545M +9.19% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $6.48B +$581M +9.85% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $6.47B +$575M +9.75% Dec 31, 2015 10-K 2018-02-20
Q3 2015 $6.47B +$567M +9.61% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $5.93B +$195M +3.4% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $5.9B +$199M +3.49% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $5.9B +$205M +3.6% Dec 31, 2014 10-K 2017-02-23
Q3 2014 $5.9B +$348M +6.27% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $5.74B +$182M +3.28% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 $5.7B +$145M +2.61% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $5.69B -$280M -4.69% Dec 31, 2013 10-K 2016-02-24
Q3 2013 $5.55B -$171M -2.99% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $5.55B -$921M -14.2% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $5.55B -$4.21B -43.1% Mar 31, 2013 10-Q/A 2013-05-07
Q4 2012 $5.97B -$3.79B -38.8% Dec 31, 2012 10-K 2015-02-25
Q3 2012 $5.72B -$4.05B -41.4% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $6.47B -$3.28B -33.7% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $9.76B +$14M +0.14% Mar 31, 2012 10-Q 2012-05-03
Q4 2011 $9.76B -$425M -4.17% Dec 31, 2011 10-K 2014-02-26
Q3 2011 $9.77B -$823M -7.77% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $9.76B -$824M -7.79% Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $9.75B -$807M -7.65% Mar 31, 2011 10-Q 2011-05-05
Q4 2010 $10.2B Dec 31, 2010 8-K 2013-05-29
Q3 2010 $10.6B Sep 30, 2010 10-Q 2010-11-05
Q2 2010 $10.6B Jun 30, 2010 10-Q 2010-08-05
Q1 2010 $10.6B Mar 31, 2010 10-Q 2010-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.